AWK vs NBIX
American Water Works (AWK) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the AWK and NBIX stock pages for the full models.
Not investment advice.